Democratic senators support surprise amendment that protects Big Pharma drug monopoly: NewsTarget.com

Consumers expecting a miracle in the Senate that would end Big Pharma's monopoly and the FDA-enforced drug racket now operating in the United States will be sorely disappointed by yesterday's events. Fifteen Democratic senators (led by Sen. Edward Kennedy) abandoned consumer interests and joined a Republican-organized amendment that would protect Big Pharma's stranglehold over U.S. consumers by blocking the importation of prescription drugs from other countries.

The amendment in question is Senate Amendment 1010: "To protect the health and safety of the public," sponsored by Sen. Thad Cochran (R-MS) as an amendment to S.1082, the FDA reauthorization bill. The short text of the amendment requires that the Secretary of Health and Human Services block all importations of medications unless HHS can certify to Congress that such imports, "pose no additional risk to the public's health and safety." HHS Secretary Mike Leavitt, of course, has no interest in allowing free market conditions to threaten Big Pharma profits, thus the outcome of this amendment is obvious: It effectively overturns the Dorgan amendment that would have allowed Americans to save billions of dollars on prescription drugs by purchasing them from outside the United States under "free market" conditions.

The conclusion of this article appears on NewsTarget.com, the independent natural health news source for consumers. This article, along with other uncensored news on important consumer health topics, can be found at:

Americans betrayed by Democratic senators with surprise amendment that protects Big Pharma monopoly

http://www.newstarget.com/021834.html

About NewsTarget

Read by over 500,000 unique readers monthly, NewsTarget is a progressive, independent natural health news site that teaches consumers how to improve their health through foods, herbs, exercise and natural therapies. The site also warns consumers about the dangers of processed foods, pharmaceuticals, chemotherapy, environmental toxins and the failure of government regulators like the FDA.